Literature DB >> 21646391

Excessive ovarian production of nerve growth factor elicits granulosa cell apoptosis by setting in motion a tumor necrosis factor α/stathmin-mediated death signaling pathway.

Cecilia Garcia-Rudaz1, Mauricio Dorfman, Srinivasa Nagalla, Konstantin Svechnikov, Olle Söder, Sergio R Ojeda, Gregory A Dissen.   

Abstract

Excessive nerve growth factor (NGF) production by the ovary, achieved via a transgenic approach, results in arrested antral follicle growth, reduced ovulatory capacity, and a predisposition to cyst formation in response to mildly elevated LH levels. Two salient features in these mutant mice (termed 17NF) are an elevated production of 17α-hydroxyprogesterone (17-OHP(4)), testosterone, and estradiol (E(2)) in response to gonadotropins, and an increased frequency of granulosa cell (GC) apoptosis. In this study, we show that the increase in steroidal response is associated with enhanced expression of Cyp17a1, Hsd17b, and Cyp19a1, which encode the enzymes catalyzing the synthesis of 17-OHP(4), testosterone, and E(2) respectively. Using a proteomic approach, we identified stathmin (STMN1), as a protein that is overproduced in 17NF ovaries. In its phosphorylated state, STMN1 mediates a cell death signal initiated by tumor necrosis factor α (TNF). STMN1 is expressed in GCs and excessive NGF increases its abundance as well as that of its forms phosphorylated at serine (Ser) 16, 25, and 38. TNF synthesis is also increased in 17NF ovaries, and this change is abolished by blocking neurotrophic tyrosine kinase receptors. Inhibiting TNF actions in vivo by administering a soluble TNF receptor prevented the increase in total and phosphorylated STMN1 production, as well as GC apoptosis in NGF-overproducing ovaries. These results indicate that an excess of NGF in the ovary promotes steroidogenesis by enhancing the expression of enzyme genes involved in 17-OHP(4), testosterone, and E(2) synthesis, and causes GC apoptosis by activating a TNF/ STMN1-mediated cell death pathway.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21646391      PMCID: PMC3302175          DOI: 10.1530/REP-11-0134

Source DB:  PubMed          Journal:  Reproduction        ISSN: 1470-1626            Impact factor:   3.906


  67 in total

Review 1.  Growth factor signaling: where is the specificity?

Authors:  M V Chao
Journal:  Cell       Date:  1992-03-20       Impact factor: 41.582

2.  Nerve growth factor receptors in the peripubertal rat ovary.

Authors:  G A Dissen; D F Hill; M E Costa; Y J Ma; S R Ojeda
Journal:  Mol Endocrinol       Date:  1991-11

3.  Phosphorylation of stathmin and other proteins related to nerve growth factor-induced regulation of PC12 cells.

Authors:  V Doye; M C Boutterin; A Sobel
Journal:  J Biol Chem       Date:  1990-07-15       Impact factor: 5.157

Review 4.  Cellular components of nerve growth factor signaling.

Authors:  J Szeberényi; P Erhardt
Journal:  Biochim Biophys Acta       Date:  1994-06-30

5.  Tumor necrosis factor-alpha gene expression in mouse oocytes and follicular cells.

Authors:  H L Chen; J L Marcinkiewicz; M Sancho-Tello; J S Hunt; P F Terranova
Journal:  Biol Reprod       Date:  1993-04       Impact factor: 4.285

6.  Prolonged and effective blockade of tumor necrosis factor activity through adenovirus-mediated gene transfer.

Authors:  J Kolls; K Peppel; M Silva; B Beutler
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-04       Impact factor: 11.205

7.  Expression of a TNF inhibitor in transgenic mice.

Authors:  K Peppel; A Poltorak; I Melhado; F Jirik; B Beutler
Journal:  J Immunol       Date:  1993-11-15       Impact factor: 5.422

8.  Multiple phosphorylation of stathmin. Identification of four sites phosphorylated in intact cells and in vitro by cyclic AMP-dependent protein kinase and p34cdc2.

Authors:  L Beretta; T Dobránsky; A Sobel
Journal:  J Biol Chem       Date:  1993-09-25       Impact factor: 5.157

9.  Expression of neurotrophins and their receptors in the mammalian ovary is developmentally regulated: changes at the time of folliculogenesis.

Authors:  G A Dissen; A N Hirshfield; S Malamed; S R Ojeda
Journal:  Endocrinology       Date:  1995-10       Impact factor: 4.736

10.  A tumor necrosis factor (TNF) receptor-IgG heavy chain chimeric protein as a bivalent antagonist of TNF activity.

Authors:  K Peppel; D Crawford; B Beutler
Journal:  J Exp Med       Date:  1991-12-01       Impact factor: 14.307

View more
  6 in total

Review 1.  Animal Models to Understand the Etiology and Pathophysiology of Polycystic Ovary Syndrome.

Authors:  Elisabet Stener-Victorin; Vasantha Padmanabhan; Kirsty A Walters; Rebecca E Campbell; Anna Benrick; Paolo Giacobini; Daniel A Dumesic; David H Abbott
Journal:  Endocr Rev       Date:  2020-07-01       Impact factor: 19.871

2.  Molecular cloning, tissue expression and SNP analysis in the goat nerve growth factor gene.

Authors:  Xiaopeng An; Long Bai; Jinxing Hou; Haibo Zhao; Jiayin Peng; Yunxuan Song; Jiangang Wang; Binyun Cao
Journal:  Mol Biol Rep       Date:  2012-10-16       Impact factor: 2.316

3.  STMN1 Promotes Progesterone Production Via StAR Up-regulation in Mouse Granulosa Cells.

Authors:  Yun-De Dou; Han Zhao; Tao Huang; Shi-Gang Zhao; Xiao-Man Liu; Xiao-Chen Yu; Zeng-Xiang Ma; Yu-Chao Zhang; Tao Liu; Xuan Gao; Lei Li; Gang Lu; Wai-Yee Chan; Fei Gao; Hong-Bin Liu; Zi-Jiang Chen
Journal:  Sci Rep       Date:  2016-06-08       Impact factor: 4.379

4.  CUMS Promotes the Development of Premature Ovarian Insufficiency Mediated by Nerve Growth Factor and Its Receptor in Rats.

Authors:  Xiaoyan Fu; Qun Zheng; Ning Zhang; Mingxing Ding; Xiaoming Pan; Wenqian Wang; Haohao Chen
Journal:  Biomed Res Int       Date:  2020-06-30       Impact factor: 3.411

5.  Obesity modulates cell-cell interactions during ovarian folliculogenesis.

Authors:  Xin Long; Qiuyun Yang; Jingjing Qian; Huiying Yao; Rui Yan; Xin Cheng; Qiancheng Zhang; Chan Gu; Fei Gao; Hongmei Wang; Lin Zhang; Fan Guo
Journal:  iScience       Date:  2021-12-13

6.  Characterization of the miRNA regulators of the human ovulatory cascade.

Authors:  G M Yerushalmi; M Salmon-Divon; L Ophir; Y Yung; M Baum; G Coticchio; R Fadini; M Mignini-Renzini; M Dal Canto; R Machtinger; E Maman; A Hourvitz
Journal:  Sci Rep       Date:  2018-10-23       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.